Search clinical trials for: S 20098

Total 2172 results

Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age (SLVP016)

Influenza

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Seasonal Influenza

Italy
Shahid Beheshti University of Medical Sciences

Completed

Antibody Response to Influenza Vaccine in Patients With Sarcoidosis (IVS)

Pulmonary Sarcoidosis

Iran, Islamic Republic of
Novartis Pharmaceuticals

Completed

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Renal Impairment

United States
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Novartis Pharmaceuticals

Terminated

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Institut de Recherches Internationales Servier

Completed

Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder

Obsessive Compulsive Disorder

Israel
Novartis Pharmaceuticals
Servier

Completed

Pharmacokinetics of AGO178 in Participants With Liver Impairment

Hepatic Impairment

United States
Novartis

Completed

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Novartis

Completed

Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder

Major Depressive Disorder

United States
Novartis

Completed

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Influenza Virus Vaccines in Children and Adults

Influenza

United States
Kaohsiung Kai-Suan Psychiatric Hospital
Ministry of Science and Technology, Taiwan; Department of Health, Executive...

Completed

Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients

Major Depressive Disorder

Taiwan
Universidad de Granada

Completed

Agomelatine in Depressed Patients With Fibromyalgia

Fibromyalgia | Major Depression

Spain
National Taiwan University Hospital

Withdrawn

The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder

Depressive Disorder, Major

Taiwan
Adimmune Corporation

Completed

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders

Influenza

Taiwan
Adimmune Corporation

Completed

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population

Influenza

Taiwan
Central Institute of Mental Health, Mannheim
Servier

Completed

Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) (AGOPSYCH)

Schizophrenia | Schizoaffective Disorder | Delusional Disorder

Germany
Shanghai Mental Health Center
Tianjin Anding Hospital

Recruiting

A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia

Schizophrenia | Negative Symptoms in Schizophrenia

China
First Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Prophylactic Effects of Agomelatine for Poststroke Depression (PRAISED)

Depression | Acute Ischemic Stroke
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects

Influenza

United Kingdom
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-20094 in T2DM Participants

Type 2 Diabetes

China
Kahramanmaras Sutcu Imam University

Completed

Melatonin Decreases Eye Pressure in Normotensive Patients

Depressive Disorder

Turkey
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects

Overweight and Obesity

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-20094 in Healthy Participants

Type 2 Diabetes

China
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

Sarcoma | Osteosarcoma

China
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Head and Neck Squamous Cell Carcinoma

China
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC)

Metastasis Castration Resistant Prostate Cancer(mCRPC)

China
National Taiwan University Hospital

Unknown

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Serology Analysis | Novel H1N1 Influenza Vaccination | Pediatric Haemato-oncology Patients

Taiwan
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

A Study of HS-20089 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Neuropharm

Completed

Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome

Fragile X Syndrome

United States
Shiga University
University of Chicago; Shionogi; Tokyo University; Showa University; Fukushima Medical... and other collaborators

Unknown

Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Japan
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Imcyse SA

Completed

IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo (IMCY-T1D-002)

Type 1 Diabetes Mellitus

United Kingdom, Belgium, France, Lithuania, Denmark, Germany, Sweden
Betta Pharmaceuticals Co., Ltd.

Completed

Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation (ICAPE)

Non-small Cell Lung Cancer

China
University Hospital, Toulouse

Completed

Combined Deep Brain Stimulation in Parkinson's Disease (SCP-FOG)

Parkinson Disease

France
Boston Scientific Corporation

Completed

Boston Scientific Post Market S-ICD Registry (EFFORTLESS)

Tachycardia, Ventricular

United Kingdom, Denmark, Italy, New Zealand, Germany, France, Netherlands, Portugal, Czechia, Spain
Zhejiang University

Unknown

Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer

Squamous Cell Carcinoma of Lung

China
Hansoh BioMedical R&D Company

Recruiting

HS-20093 in Patients With Advanced Esophageal Carcinoma and Other Advanced Solid Tumors

Advanced Solid Tumor

China
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma (ICWIP)

Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer

China
Shionogi

Completed

First-in-human Study of S-588210 (S-488210+S-488211)

Head and Neck Cancer | Esophageal Cancer | Lung Cancer | Mesothelioma | Bladder Cancer

United Kingdom
Betta Pharmaceuticals Co., Ltd.

Completed

Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH

Esophageal Carcinoma | Adenocarcinoma of the Gastroesophageal Junction

China
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency

Non-small Cell Lung Cancer

China
Second Affiliated Hospital of Soochow University

Unknown

the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease

Depression | Parkinson Disease | Sleep Disorders | Circadian Rhythm Disorders
The University of Texas Medical Branch, Galveston
Medicem International CR s.r.o.

Completed

Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S® (HOMECARE)

Labor, Induced | Cervix Uteri-Diseases

United States
Kyowa Kirin Co., Ltd.

Terminated

Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Nestlé

Completed

Stool Composition and Stool Characteristics in Healthy Term Infants Fed Human Milk or Infant Formulas

Stool Composition

Philippines
Hansoh BioMedical R&D Company

Recruiting

HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Cancer

China
Hansoh BioMedical R&D Company

Withdrawn

ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Search clinical trials for: S 20098

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations